Masamichi Motoki

Efficacy of Postinfection Treatment with Anti–Shiga Toxin (Stx) 2 Humanized Monoclonal Antibody TMA‐15 in Mice Lethally Challenged with Stx‐Producing<i>Escherichia coli</i>

Shinsuke Yamagami, Masamichi Motoki, Tsuyoshi Kimura et al. · The Journal of Infectious Diseases · 2001 · 73 citations

Role of Shiga toxin 2 (Stx2)-binding protein, human serum amyloid P component (HuSAP), in Shiga toxin-producing Escherichia coli infections: assumption from in vitro and in vivo study using HuSAP and anti-Stx2 humanized monoclonal antibody TMA-15

Tsuyoshi Kimura, Shinobu Tani, Masamichi Motoki et al. · Biochemical and Biophysical Research Communications · 2003 · 24 citations

Shiga Toxin 2, Microbial Toxin, Pathogenesis +8

Selective removal of ammonia from animal cell culture broth

Fidel Rey P. Nayve, Masamichi Motoki, Masatoshi Matsumura et al. · Cytotechnology · 1991 · 22 citations

Selective Removal, Bioremediation, Downstream Processing +2

Simultaneous ethanol fermentation and stripping process coupled with rectification

Chay B. Pham, Masamichi Motoki, Masatoshi Matsumura et al. · Journal of Fermentation and Bioengineering · 1989 · 17 citations

Process Intensification, Engineering, Bioenergy +3

Full Active Baculovirus-Expressed Human Monocyte Chemoattractant Protein 1 with the Intact N-Terminus

K. Ishii, Shinsuke Yamagami, Hiroko Tanaka et al. · Biochemical and Biophysical Research Communications · 1995 · 16 citations

Viral Pathogenesis, Immunology, Antiviral Response +4